PDE5iriociguatERAendothelin receptor antagonistRoyal Papworth HospitalCTEPHchronic thromboembolic PH (CTEPH)Pulmonary hypertensionBPA
…triuretic peptide (−67% vs −21% vs −32%, p=0.004) compared with PDE5i monotherapy and riociguat monotherapy. These differences persis…